GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
E

eFFECTOR Therapeutics EFTR · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Latest on eFFECTOR Therapeutics

Our reporting

We have not reported on eFFECTOR Therapeutics yet.

Next results

17 Nov 2026

Due on 17 Nov 2026. Analysts expect earnings of -6.40 a share on revenue of $100,000.

Past results

Reported against what analysts expected

9 May 202425 Mar 202413 Nov 20238 Aug 20239 May 20238 Mar 2023
Earnings per share-2.16-3.42-3.25-4.25-6.00-5.50
Forecast-2.16-2.73-3.25-4.75-5.50-4.50
Revenue—$162,000———$674,000
Forecast—————$660,000

Key events

  1. 12 Jan 202425-to-1 reverse split
  2. 26 Aug 20211-to-1 reverse split
  3. 8 Jan 2021Listed

eFFECTOR Therapeutics in the news

Headlines from other publishers, linked to their own pages.

Sources and methodology

Data on this tab
Our reporting and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.